CTIS.eu › Cities › Belgium › Antwerp
Antwerp
Belgium
249 total trials
85 recruiting
2022-500537-84-00
5
Moderately to severely active ulcerative colitis
2022-501417-31-00
5
High-risk Resected Melanoma
2024-515202-84-00
10
Anemia in subjects with sickle cell disease (SCD)
2024-518026-32-00
5
Invasive Breast Cancer
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
2025-521113-13-00
10
Early Parkinson’s Disease
2025-521590-13-00
5
Moderately to Severely Active Crohn’s Disease
2025-521908-22-00
10
EGFR-mutated Non-small Cell Lung Cancer
2025-523555-66-00
5
Myelofibrosis
2025-523586-18-00
5
Non-Small Cell Lung Cancer
2025-524177-16-00
4
Craving for and use of chemsex-related drugs
2025-524765-24-00
5
Rabies infection/prophylaxis
2025-524823-34-00
5
Sexually Transmitted Infections
2025-524995-53-00
6
Women with endometriosis undergoing IVF/ICSI
2025-522888-15-00
3
2026-05-27
Small Cell Lung Cancer
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
2025-522273-10-00
3
2026-02-24
Systemic Lupus Erythematosus
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
2024-518007-22-00
5
2025-12-05
Prevention of monkeypox (mpox) infection
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
2023-504478-39-00
5
2025-05-23
Squamous cell carcinoma of head and neck
2023-507936-20-00
5
2025-05-05
Acute myeloid leukemia
Showing 1–24 of 249 trials